Price target upside
Aurinia Pharmaceuticals Inc - Common Shares Price Target Upside or Downside
AUPH price target upside based on the current price and analyst average.
Direct answer
Aurinia Pharmaceuticals Inc - Common Shares's analyst target implies +10.6%.
The average target is $17.00 compared with a recorded current price of $15.37.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Aurinia Pharmaceuticals Inc - Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $15.37
- Average price target
- $17.00
- High price target
- $20.00
- Low price target
- $15.00
- Target upside
- +10.6%
- Consensus rating
- Buy
- Analysts
- 7
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026